New Hyde Park, NY, United States of America

Wen-Yi Lee

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 10.9

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Inventor Wen-Yi Lee

Introduction

Wen-Yi Lee is a prominent inventor based in New Hyde Park, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and methods for their production. With a total of six patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Wen-Yi Lee's latest patents include innovative methods for obtaining antibodies that bind to transmembrane proteins. These methods involve generating cells that express antibodies targeting transmembrane proteins, utilizing lipid bilayer-membrane scaffold protein complexes to present antigens. Another notable patent focuses on anti-SARS-CoV-2-spike glycoprotein antibodies and their fragments, which are designed to treat or prevent viral infections, specifically those caused by coronaviruses.

Career Highlights

Wen-Yi Lee is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to addressing critical health challenges through innovative solutions.

Collaborations

Wen-Yi Lee collaborates with esteemed colleagues, including Robert Babb and Gang Chen, to further enhance her research initiatives. These collaborations foster a dynamic environment for innovation and discovery.

Conclusion

Wen-Yi Lee's contributions to biotechnology and her innovative patents underscore her role as a leading inventor in her field. Her work not only advances scientific knowledge but also holds promise for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…